News – Page 455 – Endpoints News

Inventiva signs over China NASH rights to Sino Biopharm in possible $300M+ deal

3 years ago

CDMO makes an AI and drug discovery play in latest, small-time acquisition

3 years ago

Updated: Eli Lilly's RET drug notches tumor-agnostic accelerated approval, full FDA OK in NSCLC

3 years ago

The Endpoints 11: The top private biotechs in pursuit of new drugs. Pushing the envelope with powerful new ...

3 years ago

Weight loss player gets attention of RA Capital, walks away with $132M to keep pursuing big targets

3 years ago

Lending a hand to a biotech in trouble, GSK drops $75M cash to add late-stage antibiotic to portfolio

3 years ago

Servier cuts off collaboration agreement with Allogene on CD19 products, sending shares sputtering

3 years ago

Catalent’s Covid-19 vaccine manufacturing site hit with Form 483 over foreign objects in vials and other QC issues

3 years ago

Touting nine-figure deal package, Pfizer extends collaboration with AI partner

3 years ago

Are $3M gene therapies the new normal? Experts say bluebird will be a test case for a market ready for prime time

3 years ago

Q&A: Resilience boss Rahul Singhvi talks $2B US biomanufacturing initiative and post Series D deals

3 years ago

Some Medtronic insulin pumps are vulnerable to hackers, FDA warns

3 years ago

Eczema overlooked? Harris Poll finds low-key social media profile even as new meds flood the market

3 years ago

Novartis takes Gilenya fight to Supreme Court as generic competition looms

3 years ago

Updated: A week after GSK pulls one Zejula indication, FDA sets ODAC meeting to review revising label further

3 years ago

FTC chair Lina Khan to Senate: Big Pharma M&A is still a priority target

3 years ago

Merck KGaA teams up with Italian oncology group in PARP1 development deal

3 years ago

Alpine eyes $100M capital infusion; Bob Duggan lends $65M to cosmetics company-turned-biotech

3 years ago

Covid-19 roundup: Manufacturing contract axed for Valneva’s vaccine; Penny stock halts early infection trial

3 years ago

San Diego antifungal player nabs priority review for bloodstream infection treatment

3 years ago

With back-to-back PhIII wins, Pacira guns for expanded indication for post-surgery pain drug Exparel

3 years ago

Four years in the making, AbbVie and Calibr provide first look into ‘switchable’ CAR-T program

3 years ago

Carisma's CAR-M steals spotlight among 42 bidders to reverse merge with Sesen Bio

3 years ago

Boehringer sings a new tune with spokesperson Bernie Williams in newest lung disease campaign

3 years ago

First page Previous page 452 453 454455456 457 458 Next page Last page